GLP-1 drugs

“It's probably only about a fourth, 25% of employer sponsored insurance plans that today cover these drugs in terms of the benefit.”

“The first is the amount of market cap added to Lilly and Novo based on the, you know, development of GLP ones. It's like over a trillion dollars is, is more, you know, I mean, NOAA stock has decreased a lot. So you know, trillion dollars, let's say, is more th…”

“I'm guessing that more than half, especially people who come from families or communities where there's a lot of obesity are gonna be taking them.”

“I disagree. I think that some people have accumulated so much adipose tissue that it's modified their metabolism and even perhaps even brain circuitry and appetite that it's really, really helps them.”

“Nearly one in seven Americans is taking a GLP one drug. 20% have tried them.”